Honeywell plans to split into three separate companies, The Wall Street Journal reported on Thursday, news that sent shares ...

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

The stock has significantly dipped from its 52-week high of Rs 1,179.05 apiece. Nonetheless, the stock has continued to hold ...

Brokerages have recommended BUY on Info Edge due to its better-than-expected performance in Q3FY25 results. JM Financial and ...

Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common Stock. On January 13, 2025, the Company announced, on a Current Report on Form 8 ...

Regulatory impacts and market volatility continue to pose risks to certain business lines.

BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will ...

Honeywell is the worst Dow Jones stock Thursday as the industrial conglomerate's weak outlook offsets news that it is ...

Honeywell, one of the last remaining American industrial giants, announced it will split into three companies Thursday after ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...